Treatment options for fibrosis are limited and often focus on managing symptoms and slowing the progression of the disease. Anti-inflammatory and immunosuppressive drugs, such as corticosteroids and methotrexate, may be used to reduce inflammation and fibroblast activity. In some cases, antifibrotic agents like pirfenidone and nintedanib are prescribed to inhibit collagen production. Prevention strategies emphasize reducing exposure to known fibrogenic agents and adopting protective measures in occupational settings.
